<i>Hepatology International</i>｜Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection

doi:10.3969/j.issn.1001-5256.2022.3.gwjpwzjj1

Volume 38 Issue 3

Mar. 2022

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(3): 540-540

PDF( 863 KB)

Hepatology International｜Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection

DOI: 10.3969/j.issn.1001-5256.2022.3.gwjpwzjj1

Published Date: 2022-03-20

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	Hepatology International｜The prevalence of HDV among HBsAg-positive populations with and without HIV-1 in China[J]. Journal of Clinical Hepatology, 2024, 40(1): 146-146. doi: 10.12449/JCH2401.gwqkjpwzjj3
[2]	Hepatology International｜Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(2): 270-270. doi: 10.12449/JCH2402.gwqkjpwzjj2
[3]	Hepatology International｜Gut microbiota regulates circadian oscillation in hepatic ischemia-reperfusion injury-induced cognitive impairment by interfering with hippocampal lipid metabolism in mice[J]. Journal of Clinical Hepatology, 2024, 40(1): 109-109. doi: 10.12449/JCH2401.gwqkjpwzjj1
[4]	Hepatology International｜Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2023, 39(1): 21-21. doi: 10.3969/j.issn.1001-5256.2023.01.gwjpwzjj1
[5]	Hepatology International｜Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study[J]. Journal of Clinical Hepatology, 2023, 39(12): 2792-2792. doi: 10.3969/j.issn.1001-5256.2023.12.gwjpwzjj1
[6]	Hepatology International｜Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials[J]. Journal of Clinical Hepatology, 2023, 39(1): 136-136. doi: 10.3969/j.issn.1001-5256.2023.01.gwjpwzjj2
[7]	Yongqiang LI, Wenjuan TANG, Yongjian ZHOU. Role of intestinal microbiota and metabolites in the development, progression, and treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2023, 39(8): 1805-1810. doi: 10.3969/j.issn.1001-5256.2023.08.006
[8]	International Hepatology｜Intracellular labile iron is a key regulator of hepcidin expression and iron metabolism[J]. Journal of Clinical Hepatology, 2023, 39(7): 1686-1686. doi: 10.3969/j.issn.1001-5256.2023.07.gwjpwzjj2
[9]	Hepatology International｜A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study[J]. Journal of Clinical Hepatology, 2023, 39(12): 2941-2941. doi: 10.3969/j.issn.1001-5256.2023.12.gwjpwzjj2
[10]	Hepatology International｜Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection[J]. Journal of Clinical Hepatology, 2023, 39(5): 1143-1143. doi: 10.3969/j.issn.1001-5256.2023.05.gwjpwzjj2
[11]	Hepatology International｜The effectiveness of combination therapy with interferon and nucleoside analogs in pediatric patients with chronic hepatitis B: a systematic review and meta-analysis[J]. Journal of Clinical Hepatology, 2023, 39(7): 1534-1534. doi: 10.3969/j.issn.1001-5256.2023.07.gwjpwzjj1
[12]	Hepatology International｜Establishment and validation of a prognostic model for hepatitis B virus-related acute-on-chronic liver failure patients with bacterial infection[J]. Journal of Clinical Hepatology, 2022, 38(4): 901-901. doi: 10.3969/j.issn.1001-5256.2022.04.gwjpwzjj3
[13]	Hepatology International｜Diabetes is associated with the poor short-term prognosis of patients with HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2022, 38(2): 432-432. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj7
[14]	Ziwei GUO, Jiaxin ZHANG, Shuo LI, Xiaobin LI, Shun ZHU, Qian JIN, Xiaoke LI, Yongan YE. Research advances in intestinal flora and the development and prognosis of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2022, 38(5): 1137-1142. doi: 10.3969/j.issn.1001-5256.2022.05.034
[15]	Hui DENG, Bin ZHANG, Bin ZHU, Zhayier DILIHUMAER, Weixian WANG, Chunxia GUO, Dongliang YANG, Xin ZHENG, Junzhong WANG, Baoju WANG. Research advances in the role of gut microbiota in chronic hepatitis B, chronic hepatitis C, and related liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(5): 1143-1147. doi: 10.3969/j.issn.1001-5256.2022.05.035
[16]	Lidan YANG, He HE, Zhenmei AN. Role of intestinal flora in metabolic-associated fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(9): 2231-2235. doi: 10.3969/j.issn.1001-5256.2021.09.046
[17]	Yangyang XIONG, Dong WU, Jiaming QIAN. Role of gut microbiota and its metabolites in severe acute pancreatitis-related acute respiratory distress syndrome[J]. Journal of Clinical Hepatology, 2021, 37(1): 233-236. doi: 10.3969/j.issn.1001-5256.2021.01.052
[18]	Luan YuTing, Cai WenJun, Jiang ShiLi, Zhao ZhangQing, Gu HongTu, Yuan JiLi, Xing Feng, Lu: Jing, Liu ChengHai, Liu Ping, Mu YongPing. A comparative study of intestinal flora between hepatitis B cirrhosis patients with or without ascites[J]. Journal of Clinical Hepatology, 2020, 36(7): 1520-1526. doi: 10.3969/j.issn.1001-5256.2020.07.015
[19]	Wang DanDan, Song Jia, Zhang XiaoLan. Research advances in the role of gut microbiota in liver diseases[J]. Journal of Clinical Hepatology, 2019, 35(9): 2120-2123. doi: 10.3969/j.issn.1001-5256.2019.09.053
[20]	Han MeiLin, Gong ZhenHua. Mechanism of action of gut microbiota in hepatobiliary diseases[J]. Journal of Clinical Hepatology, 2017, 33(2): 384-388. doi: 10.3969/j.issn.1001-5256.2017.02.040

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (293) PDF downloads(42)

Hepatology International｜Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection

DOI: 10.3969/j.issn.1001-5256.2022.3.gwjpwzjj1

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Hepatology International｜Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection

DOI: 10.3969/j.issn.1001-5256.2022.3.gwjpwzjj1

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content